Gemcitabine and nab-paclitaxel

DRUG3 trials

Sponsors

Ability Pharmaceuticals SL, Oncolytics Biotech, Orion Corporation, Orion Pharma

Conditions

Anal Cancer MetastaticMesotheliomaNSCLC (Advanced Non-small Cell Lung Cancer)Pancreatic CancerPancreatic Cancer MetastaticSquamous Cell Carcinoma of the Anus Stage UnspecifiedUnresectable Pancreatic Carcinoma

Phase 1

A Study of ABTL0812 in Pancreatic Cancer

SuspendedNCT03417921

Ability Pharmaceuticals SLPancreatic Cancer

Start: 2021-04-26End: 2025-12-31Target: 60Updated: 2025-10-01

A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab

Active, not recruitingNCT07280377

Oncolytics BiotechAnal Cancer Metastatic, Pancreatic Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified +1

Start: 2021-10-27End: 2028-12-31Target: 122Updated: 2026-05-19

A 2-part Phase 1/2 Open-label Trial on ODM-212

RecruitingNCT07563738

Orion Corporation, Orion PharmaMesothelioma, NSCLC (Advanced Non-small Cell Lung Cancer), Pancreatic Cancer

Start: 2026-03-27End: 2029-09-01Target: 229Updated: 2026-05-04